Antonius P. Schuh
Founder at Global Source Ventures LLC
Profile
Antonius P.
Schuh is the founder of Arcturus Bioscience, Inc. (founded in 2005) and Global Source Ventures LLC (founded in 2011).
He holds the title of Chief Executive Officer at Arcturus Bioscience, Inc. in 2006 and Managing Partner at Global Source Ventures LLC since 2011.
Dr. Schuh's current job(s) include Chairman & Chief Executive Officer at selectION, Inc. and Executive Director at Gensignia, Inc.Dr. Schuh's former job(s) include President, Chief Executive Officer & Director at Sequenom, Inc. from 2000 to 2005, Chief Executive Officer at Biotheranostics, Inc. in 2008, Chairman & Chief Executive Officer at Quikbyte Software, Inc. in 2009, Chief Executive Officer & Director at Cardiff Oncology, Inc. from 2011 to 2016, President & Chief Executive Officer at Sorrento Therapeutics, Inc. in 2009, Chairman, President & Chief Executive Officer at Sorrento Therapeutics, Inc. from 2008 to 2011, Independent Director at Transgenomic, Inc. from 2009 to 2014, Independent Director at DioGenix, Inc. from 2009 to 2015, Managing Director at Sequenom GmbH, Head-Business Development at HELM AG, and Medical & Regulatory Affairs Officer at Fisons Pharmaceuticals.
Dr. Schuh obtained a doctorate degree from the University of Bonn in 1990.
Antonius P. Schuh active positions
Companies | Position | Start |
---|---|---|
Gensignia, Inc. | Director/Board Member | 2012-12-31 |
selectION, Inc.
selectION, Inc. BiotechnologyHealth Technology selectION, Inc. provides a technology platform to develop peptide blockers for ion channels. The company was founded by Andreas Klostermann and is headquartered in San Diego, CA. | Chief Executive Officer | - |
Global Source Ventures LLC
Global Source Ventures LLC Investment ManagersFinance Global Source Ventures LLC (Global Source Ventures) is a venture capital firm founded in 2011 by Antonius Schuh and Stephen Zaniboni. The firm is headquartered in San Diego, California. | Founder | 2011-05-31 |
Former positions of Antonius P. Schuh
Companies | Position | End |
---|---|---|
CARDIFF ONCOLOGY, INC. | Chief Executive Officer | 2016-03-27 |
DioGenix, Inc.
DioGenix, Inc. Medical SpecialtiesHealth Technology DioGenix, Inc. develops and commercializes novel, non-invasive diagnostic, prognostic and treatment response monitoring tests. Its program is designed to provide neurologists with a comprehensive set of clinical tests to diagnose early-stage MS, segment MS patients into clinical sub-types and predict response to treatment, all using non-invasive blood tests. The company was founded by Cam Gallagher, Douglas W. Bigwood and Larry M. Tiffany in September 2008 and is headquartered in Gaithersburg, MD. | Director/Board Member | 2014-12-31 |
Transgenomic, Inc.
Transgenomic, Inc. Medical SpecialtiesHealth Technology Transgenomic, Inc. is a global biotechnology company, which provides personalized medicine in the detection and treatment of cancer and inherited diseases through its proprietary molecular technologies and world-class clinical and research services. It operates through the following reportable segments: Laboratory Services and Genetic Assays and Platforms. The Laboratory Services segment is a combination of clinical laboratories and pharmacogenomic services business segments. The Clinical Laboratories segment specializes in genetic testing for cardiology, neurology, mitochondrial disorders and oncology. The Laboratory Services segment also provides pharmacogenomics research services supporting Phase II and Phase III clinical trials conducted by pharmaceutical companies and it employs a variety of genomic testing service technologies, including ICE COLD-PCR technology.The Genetic Assay and Platforms segment includes WAVE System product, which has broad applicability to genetic variation detection in both molecular genetic research and molecular diagnostics. This segment also manufactures and sells consumable products that can be used on multiple, independent platforms. These products include SURVEYOR Nuclease and a range of chromatography columns. Transgenomic was founded on March 6, 1997 and is headquartered in Omaha, NE. | Director/Board Member | 2014-05-13 |
SORRENTO THERAPEUTICS, INC. | Chairman | 2011-04-07 |
Quikbyte Software, Inc.
Quikbyte Software, Inc. Financial ConglomeratesFinance The Company is develops and markets Computere Software.The Company was Founded in 1989 and it's Headquartered is in Miami,FL. | Chairman | 2009-12-30 |
Training of Antonius P. Schuh
University of Bonn | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
CARDIFF ONCOLOGY, INC. | Health Technology |
SORRENTO THERAPEUTICS, INC. | Health Technology |
Private companies | 13 |
---|---|
Sequenom, Inc.
Sequenom, Inc. Medical SpecialtiesHealth Technology Sequenom, Inc. engages in the provision of early patient management information. It develops and commercializes molecular diagnostic testing services that serve women's health and oncology markets. The company was founded by Hubert Koester and Charles R. Cantor in October 09, 1996 and is headquartered in Burlington, NC. | Health Technology |
Transgenomic, Inc.
Transgenomic, Inc. Medical SpecialtiesHealth Technology Transgenomic, Inc. is a global biotechnology company, which provides personalized medicine in the detection and treatment of cancer and inherited diseases through its proprietary molecular technologies and world-class clinical and research services. It operates through the following reportable segments: Laboratory Services and Genetic Assays and Platforms. The Laboratory Services segment is a combination of clinical laboratories and pharmacogenomic services business segments. The Clinical Laboratories segment specializes in genetic testing for cardiology, neurology, mitochondrial disorders and oncology. The Laboratory Services segment also provides pharmacogenomics research services supporting Phase II and Phase III clinical trials conducted by pharmaceutical companies and it employs a variety of genomic testing service technologies, including ICE COLD-PCR technology.The Genetic Assay and Platforms segment includes WAVE System product, which has broad applicability to genetic variation detection in both molecular genetic research and molecular diagnostics. This segment also manufactures and sells consumable products that can be used on multiple, independent platforms. These products include SURVEYOR Nuclease and a range of chromatography columns. Transgenomic was founded on March 6, 1997 and is headquartered in Omaha, NE. | Health Technology |
Biotheranostics, Inc.
Biotheranostics, Inc. Medical/Nursing ServicesHealth Services Biotheranostics, Inc. develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients. It has commercialized two proprietary, highly differentiated products focused on early stage breast cancer and all metastatic cancers, Breast Cancer Index (BCI) and CancerTYPE ID (CTID). The company was founded by Thomas M. Baer in 2008 and is headquartered in San Diego, CA. | Health Services |
Quikbyte Software, Inc.
Quikbyte Software, Inc. Financial ConglomeratesFinance The Company is develops and markets Computere Software.The Company was Founded in 1989 and it's Headquartered is in Miami,FL. | Finance |
HELM AG
HELM AG Wholesale DistributorsDistribution Services HELM AG engages in the distribution of chemicals. The firm also offers chemicals, fertilizers, crop protection, and pharma products. The company was founded by Karl O. Helm in 1900 and is headquartered in Hamburg, Germany. | Distribution Services |
DioGenix, Inc.
DioGenix, Inc. Medical SpecialtiesHealth Technology DioGenix, Inc. develops and commercializes novel, non-invasive diagnostic, prognostic and treatment response monitoring tests. Its program is designed to provide neurologists with a comprehensive set of clinical tests to diagnose early-stage MS, segment MS patients into clinical sub-types and predict response to treatment, all using non-invasive blood tests. The company was founded by Cam Gallagher, Douglas W. Bigwood and Larry M. Tiffany in September 2008 and is headquartered in Gaithersburg, MD. | Health Technology |
Sorrento Therapeutics, Inc. /Old/
Sorrento Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Sorrento Therapeutics, Inc. develops human monoclonal antibodies based on its proprietary technology for research, diagnostic and therapeutic use. The company is headquartered in San Diego, CA. | Health Technology |
selectION, Inc.
selectION, Inc. BiotechnologyHealth Technology selectION, Inc. provides a technology platform to develop peptide blockers for ion channels. The company was founded by Andreas Klostermann and is headquartered in San Diego, CA. | Health Technology |
Fisons Pharmaceuticals | |
Sequenom GmbH
Sequenom GmbH Medical SpecialtiesHealth Technology Part of Laboratory Corp. of America Holdings, Sequenom GmbH is a German company that manufactures computer applications and technology systems for the diagnostic of genomic sciences. The private company is based in Hamburg, Germany. | Health Technology |
Gensignia, Inc. | |
Global Source Ventures LLC
Global Source Ventures LLC Investment ManagersFinance Global Source Ventures LLC (Global Source Ventures) is a venture capital firm founded in 2011 by Antonius Schuh and Stephen Zaniboni. The firm is headquartered in San Diego, California. | Finance |
Arcturus Bioscience, Inc.
Arcturus Bioscience, Inc. Medical SpecialtiesHealth Technology Arcturus Bioscience, Inc. develops laser capture micro dissection instruments and reagents for the analysis of microscopic tissue samples. The private company is based in Carlsbad, CA. The company was founded by Antonius P. Schuh. | Health Technology |
- Stock Market
- Insiders
- Antonius P. Schuh